GERM vs. EQRR

Last updated Aug 2, 2026

GERM (Amplify Treatments, Testing and Advancements ETF) and EQRR (ProShares Equities for Rising Rates ETF) are both exchange-traded funds - GERM is a Health & Biotech Equities fund tracking the Prime Treatments, Testing and Advancements Index, while EQRR is a Mid Cap Value Equities fund tracking the Nasdaq US Large Cap Equity Rising Rates Index. Both are passively managed. Over the past year, GERM returned 0.00% vs 40.33% for EQRR. GERM charges 0.68%/yr vs 0.35%/yr for EQRR.

Performance

GERM vs. EQRR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Treatments, Testing and Advancements ETF (GERM) and ProShares Equities for Rising Rates ETF (EQRR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

GERM

• 1D: 0.00%
• 1M: 0.00%
• 6M: 0.00%
• YTD: 0.00%
• 1Y: 0.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 0.00%

EQRR

• 1D: 1.75%
• 1M: 4.41%
• 6M: 23.60%
• YTD: 29.00%
• 1Y: 40.33%
• 3Y*: 17.69%
• 5Y*: 13.84%
• 10Y*: —
• ALL TIME*: 10.68%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
EQRR ProShares Equities for Rising Rates ETF	$235.70K	$533.46K	$2.90M
GERM Amplify Treatments, Testing and Advancements ETF	$0.00	$0.00	$0.00

GERM vs. EQRR - Yearly Performance Comparison

	2026 (YTD)	2025	2024
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%
EQRR ProShares Equities for Rising Rates ETF	29.00%	15.49%	0.58%

GERM vs. EQRR - Sectors Allocation Comparison

Sectors	GERM	EQRR
Healthcare	99.3%	-
Financial Services	0.4%	18.8%
Basic Materials	-	-
Communication Services	-	9.7%
Consumer Cyclical	-	4.3%
Consumer Defensive	-	-
Energy	-	21.6%
Industrials	-	5.5%
Real Estate	-	-
Technology	-	40.2%
Utilities	-	-

Return for Risk

GERM vs. EQRR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

GERM

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

EQRR

EQRR Risk / Return Rank: 94
EQRR Sharpe Ratio Rank: 94
EQRR Sortino Ratio Rank: 91
EQRR Omega Ratio Rank: 92
EQRR Calmar Ratio Rank: 97
EQRR Martin Ratio Rank: 96

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

GERM vs. EQRR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and ProShares Equities for Rising Rates ETF (EQRR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	GERM	EQRR	Difference
Sharpe ratio: Return per unit of total volatility	—	2.56	—
Sortino ratio: Return per unit of downside risk	—	3.30	—
Omega ratio: Gain probability vs. loss probability	—	1.46	—
Calmar ratio: Return relative to maximum drawdown	—	7.73	—
Martin ratio: Return relative to average drawdown	—	26.43	—

Drawdowns

GERM vs. EQRR - Drawdown Comparison

The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum EQRR drawdown of -57.93%. Use the drawdown chart below to compare losses from any high point for GERM and EQRR.

Drawdown Indicators

	GERM	EQRR	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-57.93%	+57.93%
Max Drawdown (1Y) Largest decline over 1 year	0.00%	-4.95%	+4.95%
Max Drawdown (3Y) Largest decline over 3 years	—	-17.75%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-21.75%	—
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	0.00%	-9.93%	+9.93%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.00%	1.45%	-1.45%

Volatility

GERM vs. EQRR - Volatility Comparison

The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while ProShares Equities for Rising Rates ETF (EQRR) has a volatility of 3.47%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than EQRR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GERM	EQRR	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.00%	3.47%	-3.47%
Volatility (6M) Calculated over the trailing 6-month period	0.00%	11.86%	-11.86%
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	14.98%	-14.98%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	21.22%	-21.22%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	24.77%	-24.77%

GERM vs. EQRR - Expense Ratio Comparison

GERM has a 0.68% expense ratio, which is higher than EQRR's 0.35% expense ratio.

Dividends

GERM vs. EQRR - Dividend Comparison

GERM has not paid dividends to shareholders, while EQRR's dividend yield for the trailing twelve months is around 1.07%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
EQRR ProShares Equities for Rising Rates ETF	1.07%	1.70%	2.17%	2.77%	2.34%	1.71%	2.17%	2.05%	2.47%	0.69%
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Which is riskier, GERM or EQRR?

EQRR has higher volatility (3.47%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs EQRR's -57.93%.

Which ETF is better, GERM or EQRR?

On 1-year performance, EQRR leads with 40.33% vs 0.00% for GERM. On fees, EQRR is cheaper at 0.35% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, GERM or EQRR?

Over the 1-year period, EQRR has performed better with a 40.33% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, GERM or EQRR?

EQRR is cheaper with a 0.35% expense ratio, compared with 0.68% for GERM.

Which ETF pays a higher dividend yield, GERM or EQRR?

EQRR has the higher dividend yield at 1.07%, compared with 0.00% for GERM.

What is the main difference between GERM and EQRR?

GERM is categorized as Health & Biotech Equities, while EQRR is Mid Cap Value Equities. GERM tracks Prime Treatments, Testing and Advancements Index, while EQRR tracks Nasdaq US Large Cap Equity Rising Rates Index. They also come from different issuers: Amplify and ProShares. Their fees differ too: 0.68% for GERM and 0.35% for EQRR.